Publications and Presentations
Claridge S, Sebag FA, Fearn S, Behar JM, Porter B, Jackson T, Sieniewicz B, Gould J, Webb J, Chen Z, O’Neill M, Gill J, Leclercq C, Rinaldi CA (2018). Cost-effectiveness of a risk-stratified approach to cardiac resynchronisation therapy defibrillators (high versus low) at the time of generator change. Heart 104(5):416-422.
Behar JM, Chin HMS, Fearn S, Ormerod JOM, Gamble J, Foley PWX, Bostock J, Claridge S, Jackson T, Sohal M, Antoniadis AP, Razavi R, Betts TR, Herring N, Rinaldi CA, (2017). Cost-effectiveness analysis of quadripolar versus bipolar left ventricular leads for cardiac resynchronization defibrillator therapy in a large, multicentre UK registry. J Am Coll Cardiol: Clinical Electrophysiology 3(2):107-16.
Chalmers N, Walker PT, Belli A-M, Thorpe AP, Sidhu PS, Robinson G, van Ransbeeck M, Fearn SA (2013). A randomised trial of the SMART™ stent versus balloon angioplasty in long, superficial femoral artery lesions: the SUPER study. Cardiovascular and Interventional Radiology 36(2):353-61. Note: this paper won the 2013 annual CVIR Editor’s Medal award.
Firth BG, Cooper LM, Fearn S (2008). The appropriate role of cost-effectiveness in determining device coverage: a case study of drug-eluting stents. Health Affairs 27(6): 1577–1586.
Gershlick AH, Fearn S (2008). Drug-eluting stents – are they worth the money? Eurointervention 4 (Suppl C): C75-C79.
Hawkins N, Sculpher MJ, Fearn S (2005). Evaluating the cost-effectiveness of drug-eluting coronary stents: the results of a Bayesian evidence synthesis and decision model. Poster presentation at Society of Medical Decision Making, October 2005.
Fearn S, Henderson I, Ireland M, Gaines P, Cleveland T (2000). How much papaverine is needed to induce maximal hyperaemia in the lower limb? Oral presentation, BSIR, November 2000.
Blows L, Fearn S, Simpson IA, Dawkins KD (2000). Biosense-guided left ventricular mapping and percutaneous direct myocardial laser revascularisation; first UK experience. Heart 83: 86.
Ahmed JM, Salame MY, Fearn S, Anthonies S, Wales C, Silverton PN, Zezulka AV, Siegel RJ, Cumberland DC (1999). Proximal reference vessel undergoes more plaque progression then distal reference vessel after coronary stenting; one-year serial intracoronary ultrasound follow up. JACC 33 (Suppl); 75A: 1159.
Ahmed JM, Salame MY, Fearn S, Anthonies S, Wales C, Silverton PN, Zezulka AV, Siegel RJ, Cumberland DC (1998). Serial ultrasound plaque evaluation after plain old balloon angioplasty (Super-POBA). Circulation 98 (Suppl); I-512: 2690.
Muthusamy TS, Kearney MT, Lindsay HS, Fearn SA and Sivananthan UM (1998). High pressure inflation is necessary for optimal deployment of the Arterial Vascular Engineering GFX intracoronary stent: evidence from a quantitative intravascular ultrasound study. Eur Heart J 19 (Suppl); P2847: 504.
Hinckley KA, Fearn SA, Howard BR and Henderson IW (1996). Glyceryl trinitrate enhances nitric oxide mediated perfusion within the equine hoof. Journal of Endocrinology 151: R1-R8.
Hinckley KA, Fearn SA, Howard BR and Henderson IW (1996). Nitric oxide donors as treatment for grass induced acute laminitis in ponies. Equine Veterinary Journal 28 (1): 17-28.
Hinckley KA, Fearn SA, Howard BR and Henderson IW (1995). Near infrared spectroscopy of pedal haemodynamics and oxygenation in normal and laminitic horses. Equine Veterinary Journal 27 (6):465-470.